Business
AstraZeneca COVID-19 vaccine: Huge setback for Australia’s hopes – Herald Sun
The coronavirus vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.
The coronavirus vaccine Australia has invested in has been dealt a major setback after researchers uncovered a suspected serious adverse reaction in a trial participant.
The vaccine, being developed by pharmaceutical giant AstraZeneca and the University of Oxford, is being tested at dozens of sites around the world.
The stage 3 trial – the final stage before safety and efficacy data can be submitted to regulators for approval – has tens of thousands of participants.
But the adverse reaction, …
-
Noosa News23 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News23 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General22 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General22 hours agoTruck driver charged with causing death by dangerous driving after highway crash